Ampio Pharmaceuticals Issues Letter To Stockholders
Ampio Pharmaceuticals Issues Letter To Stockholders
Ampio製藥公司向股東發出信函
Ampio Pharmaceuticals, Inc. (NYSE:AMPE), today released the following letter to stockholders from its Chairman, Kevin Buchi, and Chief Executive Officer, Mike Martino.
亞洲網加利福尼亞州聖何塞10月24日電安皮奧製藥公司(紐約證券交易所市場代碼：AMPE)今天發佈了其董事長凱文·布奇和首席執行官Mike·馬蒂諾致股東的以下信件。
Dear Fellow Ampio Stockholder,
親愛的Ampio股東朋友，
On behalf of the Board of Directors, we are reaching out to you directly to ask you to vote "FOR" the proposal to authorize a reverse stock-split in advance of the Ampio Special Stockholder meeting on October 13, 2022.
我們代表董事會直接與您聯繫，請您在2022年10月13日Ampio特別股東大會之前投票支持授權反向股票拆分的提議。
As many of you are aware, the NYSE Regulation has determined that the Company is no longer suitable for listing on the NYSE American Exchange ("Exchange") due to the abnormally low trading price of its...
正如你們許多人所知，紐約證券交易所的法規已經確定，由於其普通股的交易價...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間